DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Intra-Cellular Therapies Inc. (ITCI)
« Back to company indexITCI Chatter Timeline
Stock Ticker for ITCI
Most Active Tweeters for ITCI
| User | Tweets |
|---|---|
| @Tickeron | 10 |
| @AmericanBanking | 7 |
| @biotechw2019 | 6 |
| @WeekHerald | 5 |
| @TickerReport | 5 |
Recent Tweets for ITCI
 |
@ConsumerFeed Brokerages Set Intra-Cellular Therapies Inc $ITCI Price Target at $22.64 https://t.co/cKbxITU3NT November 10th 2019, 3:11pm |
 |
@1MinuteStock Wondering about #sentiment indicator for $ITCI? The Short Ratio is 9.18% https://t.co/HSQYtjAAmj November 10th 2019, 7:11am |
|
@1MinuteStock Wondering about risks of $ITCI? The 63-day volatility is 24.61% https://t.co/uqiAroAdgS November 10th 2019, 7:11am |
 |
@stocknewstimes FY2019 EPS Estimates for Intra-Cellular Therapies Inc Raised by Svb Leerink $ITCI https://t.co/YaCKQN8kCP November 10th 2019, 6:11am |
 |
@TheMarketsDaily FY2019 EPS Estimates for Intra-Cellular Therapies Inc Raised by Svb Leerink $ITCI https://t.co/GEp2jWBuyS November 10th 2019, 6:11am |
 |
@dakotafinancial Intra-Cellular Therapies Inc Forecasted to Post FY2019 Earnings of -$2.88 Per Share $ITCI https://t.co/QfYn2J4mo4 November 10th 2019, 6:11am |
 |
@Tickeron $ITCI's Aroon indicator drops into Downtrend on November 8, 2019. View odds for this and other indicators:… https://t.co/VaROCdgEPV November 10th 2019, 12:11am |
 |
@gcassidy718 $ITCI reasonable changes in stock price 2.24 % change recently https://t.co/pg77CdHU2e November 9th 2019, 10:11pm |
|
@dakotafinancial Intra-Cellular Therapies $ITCI Stock Price Down 5.6% https://t.co/i7ninviPM5 November 9th 2019, 5:11pm |
 |
@SwingTradeBot Recent $ITCI technical alerts: 180 Bullish Setup plus 8 more alerts... https://t.co/xs6K8oSF6z November 9th 2019, 3:11pm |
|
@1MinuteStock Unicorn Bay rating for $ITCI is 1.95 out of 5. https://t.co/PReJ5a3jpk November 9th 2019, 2:11pm |
|
@1MinuteStock Recommendation #HOLD for $ITCI with UB rating - 1.95 out of 5. https://t.co/QA9kJO4YPT November 9th 2019, 2:11pm |
|
@Tickeron $ITCI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/6gbvMo2PX3 November 9th 2019, 3:11am |
 |
@WeekHerald Research Analysts Set Expectations for Intra-Cellular Therapies Inc’s FY2019 Earnings $ITCI https://t.co/cEX0tNTb0B November 9th 2019, 2:11am |
 |
@TranscriptDaily FY2019 EPS Estimates for Intra-Cellular Therapies Inc $ITCI Increased by Analyst https://t.co/eg1LXioSAs November 9th 2019, 2:11am |
 |
@OlympiaReport Equities Analysts Issue Forecasts for Intra-Cellular Therapies Inc’s FY2019 Earnings $ITCI https://t.co/eA0h70QDtV November 9th 2019, 2:11am |
 |
@dispatchtribune Equities Analysts Issue Forecasts for Intra-Cellular Therapies Inc’s FY2019 Earnings $ITCI https://t.co/bJLEUapY8J November 9th 2019, 2:11am |
 |
@ThisLincolnian Research Analysts Set Expectations for Intra-Cellular Therapies Inc’s FY2019 Earnings $ITCI https://t.co/raZDZD6kc7 November 9th 2019, 2:11am |
|
@TranscriptDaily FY2019 EPS Estimates for Intra-Cellular Therapies Inc $ITCI Boosted by Jefferies Financial Group https://t.co/QR0hyYAbXd November 8th 2019, 11:11am |
 |
@AmericanBanking Intra-Cellular Therapies Inc $ITCI to Post FY2019 Earnings of -$2.77 Per Share, Cantor Fitzgerald Forecasts https://t.co/AE4PSUs8mZ #stocks November 8th 2019, 11:11am |
|
@AmericanBanking FY2019 EPS Estimates for Intra-Cellular Therapies Inc $ITCI Raised by Analyst https://t.co/Fabysy7JJJ #stocks November 8th 2019, 11:11am |
|
@AmericanBanking Analysts Set Expectations for Intra-Cellular Therapies Inc’s FY2019 Earnings $ITCI https://t.co/EQTZfp2GPP #stocks November 8th 2019, 11:11am |
 |
@EnterpriseLeade FY2019 EPS Estimates for Intra-Cellular Therapies Inc $ITCI Raised by Analyst https://t.co/QNDA87YTnM November 8th 2019, 10:11am |
|
@stocknewstimes Analysts Set Expectations for Intra-Cellular Therapies Inc’s FY2019 Earnings $ITCI https://t.co/JEcq0DdcAD November 8th 2019, 10:11am |
|
@TheMarketsDaily Intra-Cellular Therapies Inc $ITCI to Post FY2019 Earnings of -$2.77 Per Share, Cantor Fitzgerald Forecasts https://t.co/Z15w0MLgEp November 8th 2019, 10:11am |
|
@dispatchtribune FY2019 EPS Estimates for Intra-Cellular Therapies Inc $ITCI Raised by Analyst https://t.co/rc5lVDXnUV November 8th 2019, 10:11am |
|
@Tickeron $ITCI in Uptrend: RSI indicator stops in overbought zone for 5 days. View odds for this and other indicators:… https://t.co/YzYYxv6gyQ November 7th 2019, 10:11pm |
 |
@Gambiste1 RT @biotechw2019: $ITCI still not a convincing break along 100 DMA very low vol ! https://t.co/0zzjYDawpz November 7th 2019, 4:11pm |
 |
@biotechw2019 $ITCI still not a convincing break along 100 DMA very low vol ! https://t.co/0zzjYDawpz November 7th 2019, 2:11pm |
|
@AmericanBanking Intra-Cellular Therapies Inc $ITCI Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/CKnEfftVRb #stocks November 7th 2019, 2:11pm |
 |
@TickerReport Intra-Cellular Therapies $ITCI Posts Quarterly Earnings Results, Beats Estimates By $0.17 EPS https://t.co/QXNRGSxjAW November 7th 2019, 11:11am |
 |
@dailypoliticaln Intra-Cellular Therapies $ITCI Announces Earnings Results, Beats Expectations By $0.17 EPS https://t.co/36C3OjUk98 November 7th 2019, 11:11am |
|
@Gambiste1 RT @DataTrials: $ITCI Phase 1|Phase 2 Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients Wi… November 7th 2019, 7:11am |
|
@Gambiste1 RT @biotechw2019: $ITCI a little bit of struggle to clear the cloud for 4 days with low vol. still watching. a solid clear with vol may sen… November 7th 2019, 7:11am |
 |
@DataTrials $ITCI Phase 1|Phase 2 Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Pat… https://t.co/QfCVrl0YbZ November 7th 2019, 7:11am |
|
@biotechw2019 $ITCI a little bit of struggle to clear the cloud for 4 days with low vol. still watching. a solid clear with vol m… https://t.co/WRAuprdQw1 November 7th 2019, 7:11am |
|
@EnterpriseLeade Intra-Cellular Therapies $ITCI Issues Quarterly Earnings Results https://t.co/V9Zp3xqCHw November 6th 2019, 11:11pm |
|
@dispatchtribune Intra-Cellular Therapies $ITCI Posts Earnings Results, Beats Expectations By $0.17 EPS https://t.co/suEYkZueDN November 6th 2019, 11:11pm |
|
@TheMarketsDaily Intra-Cellular Therapies $ITCI Announces Quarterly Earnings Results, Beats Estimates By $0.17 EPS https://t.co/AUc7AkAW94 November 6th 2019, 11:11pm |
|
@stocknewstimes Intra-Cellular Therapies $ITCI Announces Earnings Results https://t.co/UX5Kl7R78o November 6th 2019, 10:11pm |
|
@Tickeron $ITCI in Uptrend: RSI indicator stops in overbought zone for 4 days. View odds for this and other indicators:… https://t.co/oLuOC3HFQB November 6th 2019, 10:11pm |
|
@ThisLincolnian Intra-Cellular Therapies $ITCI Announces Earnings Results, Beats Expectations By $0.17 EPS https://t.co/jHuvkFHAIa November 6th 2019, 9:11pm |
|
@AmericanBanking Intra-Cellular Therapies $ITCI Announces Earnings Results, Beats Expectations By $0.17 EPS https://t.co/bBDwnXItuu #stocks November 6th 2019, 9:11pm |
|
@WeekHerald Intra-Cellular Therapies $ITCI Announces Earnings Results, Beats Expectations By $0.17 EPS https://t.co/vBXU9sLROX November 6th 2019, 9:11pm |
|
@biotechw2019 $ITCI it has been chopping/shaking bulls and bears at 100 DMA and top of the cloud. https://t.co/QBRvMhWjym November 6th 2019, 7:11am |
 |
@semodough $ITCI had $255.4 million in cash, which we believe will carry them into 1H 2021. Lumateperone NDA schizophrenia PDUFA on December 27, 2019 November 6th 2019, 7:11am |
|
@stocknewstimes ValuEngine Downgrades Intra-Cellular Therapies $ITCI to Hold https://t.co/sFPM6PyuzG November 6th 2019, 12:11am |
|
@TheMarketsDaily ValuEngine Downgrades Intra-Cellular Therapies $ITCI to Hold https://t.co/VouwBB4T2X November 6th 2019, 12:11am |
|
@TranscriptDaily ValuEngine Downgrades Intra-Cellular Therapies $ITCI to Hold https://t.co/nmIXv6LLoR November 6th 2019, 12:11am |
|
@WeekHerald ValuEngine Downgrades Intra-Cellular Therapies $ITCI to Hold https://t.co/MLh2NpWzh6 November 6th 2019, 12:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.